Abstract
High-dose thiotepa has been successfully included in a variety of conditioning regimens for stem cell transplantation in hematological and solid neoplasms. Toxicity of high-dose thiotepa mainly manifests as profound myeloablation and some degree of liver damage. We report a case of inappropriate secretion of antidiuretic hormone (SIADH) in a patient with primary CNS lymphoma who underwent therapy with high-dose thiotepa.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sica, S., Cicconi, S., Sorà, F. et al. Inappropriate antidiuretic hormone secretion after high-dose thiotepa. Bone Marrow Transplant 24, 571–572 (1999). https://doi.org/10.1038/sj.bmt.1701922
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1701922
Keywords
This article is cited by
-
The syndrome of inappropriate secretion of antidiuretic hormone associated with SCT: clinical differences following SCT using cord blood and BM/peripheral blood
Bone Marrow Transplantation (2008)
-
Hyponatremia and syndrome of inappropriate antidiuretic hormone secretion complicating stem cell transplantation
Bone Marrow Transplantation (2004)
